-
POET Technologies Inc. (TSXV: PTK; NASDAQ: POET)
POET Technologies is a leader in the silicon photonics trend that’s changing the semiconductor game—moving data at light speed for today’s data-hungry technologies. POET is taking optical data transmission to the next level with our proven method for efficiently integrating photonics and electronics. The centerpiece: our patented Optical Interposer, which consolidates components onto a single, scalable platform that dramatically reduces assembly time and cuts costs by as much as half. In short, POET is lighting the way in hybrid silicon photonics—for applications ranging from data centers to health sensors, IoT to 5G, AI to EV.
Thomas Mika
EVP & Chief Financial Officer
Thomas Mika previously served as the Chairman of the Board of Rennova Health, the successor company to CollabRx and previously Tegal Corporation, a semiconductor capital equipment company. On the Board of Tegal following its spin-out from Motorola in 1989, Mika assumed the roles of CFO in 2002, CEO in 2005 and Chairman & CEO in 2006. In 2015, Tegal merged with Rennova Health with Mika retaining the position of Chairman until joining POET in November 2016. Previously, Mika co-founded IMTEC, a boutique investment and consulting firm, serving clients in the U.S., Europe and Japan over a period of 20 years. Earlier in his career, Mika was a managing consultant with Cresap, McCormick & Paget and a policy analyst for the National Science Foundation. He holds a Bachelor of Science in Microbiology from the University of Illinois at Urbana-Champaign and a Master of Business Administration from the Harvard Graduate School of Business.